pentolinium tartrate has been researched along with Hyperparathyroidism in 1 studies
Pentolinium Tartrate: A nicotinic antagonist that has been used as a ganglionic blocking agent in hypertension.
pentolinium tartrate : The bitartrate salt of pentolinium.
Hyperparathyroidism: A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patterson, M | 1 |
| Wolma, F | 1 |
| Drake, A | 1 |
| Ong, H | 1 |
1 other study available for pentolinium tartrate and Hyperparathyroidism
| Article | Year |
|---|---|
Gastric secretion and chronic hyperparathyroidism.
Topics: Adult; Female; Gastric Acidity Determination; Gastric Juice; Humans; Hyperparathyroidism; Male; Midd | 1969 |